Cyclerion Therapeutics
(NASDAQ) CYCN
Cyclerion Therapeutics Financials at a Glance
Market Cap
$12.51M
Revenue (TTM)
$2.07M
Net Income (TTM)
$3.53M
EPS (TTM)
$-1.18
P/E Ratio
-2.46
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Price
$3.24
Volume
5,547
Open
$2.85
Price
$3.24
Volume
5,547
Open
$2.85
Previous Close
$3.24
Daily Range
$2.85 - $3.26
52-Week Range
$1.03 - $8.48
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Price
$3.24
Volume
5,547
Open
$2.85
Previous Close
$3.24
Daily Range
$2.85 - $3.26
52-Week Range
$1.03 - $8.48
CYCN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cyclerion Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
1
CEO
Regina Graul, PhD
Website
www.cyclerion.comHeadquarters
Cambridge, MA 02142, US
CYCN Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-39%
Return on Capital
-55%
Return on Assets
-35%
Earnings Yield
-40.65%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$12.51M
Shares Outstanding
4.33M
Volume
5.55K
Short Interest
0.00%
Avg. Volume
4.72M
Financials (TTM)
Gross Profit
$2.07M
Operating Income
$4.97M
EBITDA
$4.97M
Operating Cash Flow
$3.31M
Capital Expenditure
$0.00
Free Cash Flow
$3.31M
Cash & ST Invst.
$3.24M
Total Debt
$0.00
Cyclerion Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.02M
-43.2%
Gross Profit
$1.02M
-43.2%
Gross Margin
100.00%
N/A
Market Cap
$12.51M
N/A
Market Cap/Employee
$12.51M
N/A
Employees
1
N/A
Net Income
$799.00K
-250.8%
EBITDA
$838.00K
-266.9%
Quarterly Fundamentals
Net Cash
$3.24M
+0.2%
Accounts Receivable
$1.00M
+79.9%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-35.33%
N/A
Return on Invested Capital
-54.74%
N/A
Free Cash Flow
$1.58M
-538.6%
Operating Cash Flow
$1.58M
-538.6%